Rheumatoid Arthritis Quiz: Understanding Biosimilars in RA

Is the following statement true or false?

A manufacturer developing a biosimilar will need to demonstrate that its product is highly similar to the reference product in terms of purity, chemical identity, and bioactivity, but will not need to undertake any clinical trials to demonstrate safety and efficacy.